
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7766929
[patent_doc_number] => 20120034617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'ASSAYS FOR BACTERIAL DETECTION AND IDENTIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/258259
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10643
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034617.pdf
[firstpage_image] =>[orig_patent_app_number] => 13258259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/258259 | ASSAYS FOR BACTERIAL DETECTION AND IDENTIFICATION | Mar 30, 2010 | Abandoned |
Array
(
[id] => 6063270
[patent_doc_number] => 20110201092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'LISTERIA ATTENUATED FOR ENTRY INTO NON-PHAGOCYTIC CELLS, VACCINES COMPRISING THE LISTERIA, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/748586
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 32880
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748586
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748586 | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof | Mar 28, 2010 | Issued |
Array
(
[id] => 4619354
[patent_doc_number] => 07999074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Bacteriocins and novel bacterial strains'
[patent_app_type] => utility
[patent_app_number] => 12/727660
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11496
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/999/07999074.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727660 | Bacteriocins and novel bacterial strains | Mar 18, 2010 | Issued |
Array
(
[id] => 4463137
[patent_doc_number] => 07935357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species'
[patent_app_type] => utility
[patent_app_number] => 12/728177
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 11321
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728177 | Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species | Mar 18, 2010 | Issued |
Array
(
[id] => 9691570
[patent_doc_number] => 08822163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Method for measuring β-glucan, and β-glucan-binding protein for use in the method'
[patent_app_type] => utility
[patent_app_number] => 13/257080
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 34057
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257080 | Method for measuring β-glucan, and β-glucan-binding protein for use in the method | Mar 16, 2010 | Issued |
Array
(
[id] => 4575926
[patent_doc_number] => 07855282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-21
[patent_title] => 'Protein, a gene encoding therefor and a method of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/716182
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15742
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/855/07855282.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716182 | Protein, a gene encoding therefor and a method of using the same | Mar 1, 2010 | Issued |
Array
(
[id] => 6420756
[patent_doc_number] => 20100150956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'MULTICOMPONENT VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/710790
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27540
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20100150956.pdf
[firstpage_image] =>[orig_patent_app_number] => 12710790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/710790 | Multicomponent vaccines | Feb 22, 2010 | Issued |
Array
(
[id] => 6320536
[patent_doc_number] => 20100196380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Babesia Subtilisin'
[patent_app_type] => utility
[patent_app_number] => 12/707953
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14482
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196380.pdf
[firstpage_image] =>[orig_patent_app_number] => 12707953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/707953 | Babesia Subtilisin | Feb 17, 2010 | Abandoned |
Array
(
[id] => 4467960
[patent_doc_number] => 07943143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/703631
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7179
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943143.pdf
[firstpage_image] =>[orig_patent_app_number] => 12703631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/703631 | Chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion protein and uses thereof | Feb 9, 2010 | Issued |
Array
(
[id] => 6347290
[patent_doc_number] => 20100330618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Methods for producing biological substances in pigment-deficient mutants of bacillus cells'
[patent_app_type] => utility
[patent_app_number] => 12/703550
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11818
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330618.pdf
[firstpage_image] =>[orig_patent_app_number] => 12703550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/703550 | Methods for producing biological substances in pigment-deficient mutants of bacillus cells | Feb 9, 2010 | Issued |
Array
(
[id] => 8963025
[patent_doc_number] => 20130202627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'USE OF FLAGELLINS FROM THE GENUS MARINOBACTER AS VACCINATION ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 13/576764
[patent_app_country] => US
[patent_app_date] => 2010-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12424
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576764
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/576764 | Use of flagellins from the genus Marinobacter as vaccination adjuvants | Feb 1, 2010 | Issued |
Array
(
[id] => 5952458
[patent_doc_number] => 20110033484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'LprG AS A CHAPERONE OF IMMUNE ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 12/693896
[patent_app_country] => US
[patent_app_date] => 2010-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7849
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033484.pdf
[firstpage_image] =>[orig_patent_app_number] => 12693896
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693896 | LprG as a chaperone of immune adjuvants | Jan 25, 2010 | Issued |
Array
(
[id] => 6568532
[patent_doc_number] => 20100273187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'ANTIBODIES AGAINST DELTA-5 DESATURASE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/686781
[patent_app_country] => US
[patent_app_date] => 2010-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10911
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12686781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/686781 | Antibodies against delta-5 desaturase and uses thereof | Jan 12, 2010 | Issued |
Array
(
[id] => 6228836
[patent_doc_number] => 20100183574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'LACTIC ACID BACTERIA AND THEIR USE IN SWINE DIRECT-FED MICROBIALS'
[patent_app_type] => utility
[patent_app_number] => 12/685979
[patent_app_country] => US
[patent_app_date] => 2010-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15024
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12685979
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/685979 | Lactic acid bacteria and their use in swine direct-fed microbials | Jan 11, 2010 | Issued |
Array
(
[id] => 7527034
[patent_doc_number] => 08043625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Purified plasmodium and vaccine compositions'
[patent_app_type] => utility
[patent_app_number] => 12/684863
[patent_app_country] => US
[patent_app_date] => 2010-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13688
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/043/08043625.pdf
[firstpage_image] =>[orig_patent_app_number] => 12684863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/684863 | Purified plasmodium and vaccine compositions | Jan 7, 2010 | Issued |
Array
(
[id] => 7500648
[patent_doc_number] => 20110263047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'PEPTIDE TAG AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/141899
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10640
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263047.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141899 | PEPTIDE TAG AND USES THEREOF | Dec 22, 2009 | Abandoned |
Array
(
[id] => 3857
[patent_doc_number] => 07816086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Genes of an otitis media isolate of nontypeable Haemophilus influenzae'
[patent_app_type] => utility
[patent_app_number] => 12/646424
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26713
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816086.pdf
[firstpage_image] =>[orig_patent_app_number] => 12646424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/646424 | Genes of an otitis media isolate of nontypeable Haemophilus influenzae | Dec 22, 2009 | Issued |
Array
(
[id] => 4628935
[patent_doc_number] => 08007817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Compositions and methods for treating microbial infections'
[patent_app_type] => utility
[patent_app_number] => 12/640157
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/007/08007817.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640157
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640157 | Compositions and methods for treating microbial infections | Dec 16, 2009 | Issued |
Array
(
[id] => 6413121
[patent_doc_number] => 20100166800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'RECOMBINANT ATTENUATED CLOSTRIDIUM ORGANISMS AND VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/640645
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12815
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640645 | Recombinant attenuated Clostridium organisms and vaccine | Dec 16, 2009 | Issued |
Array
(
[id] => 7586747
[patent_doc_number] => 20110281257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'METHOD FOR PRODUCING BETA-SANTALENE'
[patent_app_type] => utility
[patent_app_number] => 13/124866
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11254
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281257.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124866
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124866 | Method for producing beta-santalene | Dec 8, 2009 | Issued |